Showing results (31-40 of 110) with videos related to
Sort By:
Pageof 11
Orphanet Journal of Rare Diseases|May 24, 2017
Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective studyAbdellatif Tazi, Gwenaël Lorillon, Julien Haroche, et al.Therapie|August 8, 2014
Translational research in immune and inflammatory diseases; what are the challenges, expected advances, and innovative therapies?Jean-Michel Joubert, Jacques-Eric Gottenberg, Gilles Paintaud, et al.The Journal of Allergy and Clinical Immunology|September 21, 2020
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trialFlorence Roufosse, Jean-Emmanuel Kahn, Marc E Rothenberg, et al.Circulation|July 14, 2017
Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 PatientsCloé Comarmond, Lucie Biard, Marc Lambert, et al.Journal of Autoimmunity|August 21, 2018
Overall survival and mortality risk factors in Takayasu's arteritis: A multicenter study of 318 patientsAdrien Mirouse, Lucie Biard, Cloé Comarmond, et al.Blood|August 24, 2010
Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndromeBenjamin Terrier, Ivan Bièche, Thierry Maisonobe, et al.Journal of Autoimmunity|June 26, 2026
High-intensity immunosuppression versus modern standard care in poor-prognosis diffuse cutaneous systemic sclerosis: A propensity-matched studyLucas Khellaf, Rémi Khellaf, Pierre Pinson, et al.Stroke|March 31, 2022
Cerebrovascular Ischemic Events in Patients With Takayasu ArteritisAdrien Mirouse, Sandrine Deltour, Delphine Leclercq, et al.Stroke|July 26, 2021
FIP1L1-PDGFRA-Associated Hypereosinophilic Syndrome as a Treatable Cause of Watershed InfarctionJuliette Tennenbaum, Matthieu Groh, Laura Venditti, et al.The Journal of Rheumatology|May 9, 2008
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label studyAlice Bérezné, Brigitte Ranque, Dominique Valeyre, et al.Pageof 11